Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine : A Prospective Study of Phase 3 Clinical Trial Participants
| dc.contributor.author | Arastoo, Mohammad | |
| dc.contributor.author | Mazanetz, Michael P. | |
| dc.contributor.author | Miller, Sonya | |
| dc.contributor.author | Shiells, Helen | |
| dc.contributor.author | Hull, Claire | |
| dc.contributor.author | Robinson, Keith | |
| dc.contributor.author | Storey, John M.D. | |
| dc.contributor.author | Harrington, Charles R. | |
| dc.contributor.author | Wischik, Claude M. | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Chemistry | en |
| dc.contributor.institution | University of Aberdeen.Neuroscience | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2023-11-02T15:52:00Z | |
| dc.date.available | 2023-11-02T15:52:00Z | |
| dc.date.issued | 2023-09-06 | |
| dc.description | Funding Information: This work was funded by TauRx Therapeutics Ltd., Singapore. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 2854430 | |
| dc.identifier | 281767583 | |
| dc.identifier | 21044f7c-2fab-43d8-a3ea-4e57ad65b899 | |
| dc.identifier | 85172769943 | |
| dc.identifier | 37762050 | |
| dc.identifier.citation | Arastoo, M, Mazanetz, M P, Miller, S, Shiells, H, Hull, C, Robinson, K, Storey, J M D, Harrington, C R & Wischik, C M 2023, 'Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine : A Prospective Study of Phase 3 Clinical Trial Participants', International Journal of Molecular Sciences, vol. 24, no. 18, 13747. https://doi.org/10.3390/ijms241813747 | en |
| dc.identifier.doi | 10.3390/ijms241813747 | |
| dc.identifier.iss | 18 | en |
| dc.identifier.issn | 1661-6596 | |
| dc.identifier.other | ORCID: /0000-0002-5261-5467/work/146067516 | |
| dc.identifier.other | ORCID: /0000-0002-0805-4949/work/146067800 | |
| dc.identifier.other | ORCID: /0000-0003-2250-3920/work/173415885 | |
| dc.identifier.uri | https://hdl.handle.net/2164/22092 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85172769943&partnerID=8YFLogxK | en |
| dc.identifier.vol | 24 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | International Journal of Molecular Sciences | en |
| dc.subject | anti-hypoxaemia | en |
| dc.subject | COVID-19 | en |
| dc.subject | hydromethylthionine | en |
| dc.subject | hypoxaemia | en |
| dc.subject | SARS-CoV-2 | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject | Catalysis | en |
| dc.subject | Molecular Biology | en |
| dc.subject | Spectroscopy | en |
| dc.subject | Computer Science Applications | en |
| dc.subject | Physical and Theoretical Chemistry | en |
| dc.subject | Organic Chemistry | en |
| dc.subject | Inorganic Chemistry | en |
| dc.subject.lcc | RM | en |
| dc.title | Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine : A Prospective Study of Phase 3 Clinical Trial Participants | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Arastoo_etal_IJMS_Exploring_the_Anti-Hypoxaemia_VOR.pdf
- Size:
- 2.72 MB
- Format:
- Adobe Portable Document Format
